A major new study published in JAMA Network Open delivers a message that is both powerful and deeply personal for those of us who have faced breast cancer. Breast cancer survival rates are better with standard, evidence-based breast cancer treatment.
For patients navigating overwhelming decisions after diagnosis, this research cuts through the noise—and reinforces what decades of science have already shown.
What the Study Found: Breast Cancer Survival Rates Better with Standard Treatment
This large-scale study examined outcomes in women with breast cancer who:
- Followed guideline-recommended medical treatment
- Used alternative therapies instead of standard care
- Combined complementary approaches with conventional treatment
Key findings:
- Women who refused standard treatments (like surgery, chemotherapy, radiation, or endocrine therapy) had a significantly higher risk of death
- Using alternative medicine alone was associated with worse survival outcomes
- Adding complementary therapies did not improve survival when used alongside standard care
- The strongest predictor of survival was adherence to evidence-based treatment protocols
This wasn’t a small or niche study. It analyzed large patient populations over time—meaning, the data on breast cancer survival rates (over 2M individuals participating) is robust. The conclusions are clear.
Why Standard Breast Cancer Treatment Works
Breast cancer is one of the most studied diseases in modern medicine. Over decades, treatments have been rigorously tested, refined, and optimized.
According to the National Cancer Institute, advances in treatment have contributed to steadily improving survival rates.
Standard treatment may include:
- Surgery (lumpectomy or mastectomy)
- Chemotherapy
- Radiation therapy
- Endocrine (hormone) therapy
For hormone receptor–positive cancers, endocrine therapies like Letrozole play a critical role in reducing recurrence risk.
Guidelines from the National Comprehensive Cancer Network (NCCN) and American Society of Clinical Oncology (ASCO) are based on extensive clinical evidence—and are continuously updated as new research emerges.
My Experience: Choosing Evidence-Based Care
I was diagnosed with stage 2B ER/PR+ Her2- multi-focal breast cancer.
Based on the recommendations of my care team, I made the decision to have surgery, chemotherapy, radiation, and I am on ongoing endocrine therapy with Letrozole.
Not because it was easy—but because it was proven.
This study reinforces what I believed then and believe even more strongly now. Traditional therapies improve breast cancer survival rates.
The Risk of Choosing Alternative Therapy Alone
Understandably, many patients look for less invasive or more “natural” options when facing a breast cancer diagnosis.
You may hear:
- “There are gentler ways”
- “Avoid chemo at all costs”
- “I can’t do the drugs”
- “Try this instead”
- “So and so lived for years using X”
But this study makes one thing very clear. There is no evidence that alternative therapies alone can treat breast cancer effectively or that positively impacts breast cancer survival rates
In fact, choosing them instead of medical treatment can:
- Delay critical care
- Allow cancer to progress
- Reduce survival outcomes
Organizations like the American Cancer Society emphasize that complementary therapies can support well-being—but should never replace standard treatment.
Where Complementary Care Fits In
This is not an either/or conversation. Many patients benefit from complementary approaches to manage their side effects, support their mental health and improve quality of life, in addition to improving their breast cancer survivor rates.
These might include:
- Nutrition support
- Mindfulness or stress reduction
- Physical activity like yoga
But the key distinction is this. Complementary care supports treatment. It does not replace it.
Side note: If you are planning to take supplements, PLEASE talk to your oncologist first. Some can interfere with traditional treatments and undermine their efficacy.
The Role of Information, Trust, and Patient Empowerment
Today, patients are navigating more information than ever—online, on social media, and increasingly through AI tools. That can be empowering—but also overwhelming and confusing.
Cognitive overload is real. And when you’re newly diagnosed, it can make it harder to:
- Interpret medical information
- Weigh risks and benefits
- Make confident decisions
That’s why trusted, evidence-based information from authoritative sources matters.
It’s also why tools like AskEllyn exist—to provide emotional support, to offer clear, grounded non-medical information that supports your care team and your care journey, and finally, to offer a safe space where you can ask questions and share your worries. AskEllyn will never replace your care team—but she will help support you engage more confidently with it.
Related Reading on AskEllyn
To go deeper, explore:
- https://askellyn.ai/two-new-breast-cancer-breakthroughs-that-are-exciting-us/
- https://askellyn.ai/the-butterfly-effect-guide-small-actions-big-change/
- https://askellyn.ai/fda-lifts-warnings-on-hormone-replacement-therapy/
These resources expand on how patients can:
- Navigate complex decisions
- Build trust in their care
- Access emotional and psychosocial support
The Bottom Line: Evidence Matters
This study reinforces a truth that every patient deserves to hear clearly. Breast cancer survival rates are improved by traditional, evidence-proven treatments.
It’s not perfect. It’s hard to undergo. It changes your life forever.
But it is the reason survival rates continue to improve worldwide.
And for many of us—including me—it’s the reason we’re still here.
